Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome is a research paper published in EBioMedicine (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Kinderkrebsstiftung der Deutschen Leukamie-Forschungshilfe
Grant: DKS 2024.03
H2020 Marie Skłodowska-Curie Actions
Grant: 846806
P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis
Federal Ministry of Education and Research Bonn Office
Grant: 01GM2205A
National Cancer Institute
Grant: R01CA240924
National Cancer Institute
Grant: R01AI081848
National Cancer Institute
Grant: P30CA008748
National Cancer Institute
Grant: U01CA228963
Fields of Study
Keywords